-+ 0.00%
-+ 0.00%
-+ 0.00%

KALVISTA PHARMACEUTICALS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM; RAISES TARGET PRICE TO $27 FROM $22

Reuters·04/30/2026 05:51:51

Please log in to view news